Label expansion

Showing 6 of 0 results

• Using real-world evidence for label expansion: Use of palbociclib in male breast cancer patients

  Clinical Pharmacology & Therapeutics

  • Real-world evidence
  • Publication summary
  • Publications
  • Label expansion
  • Unmet need
  • Metastatic breast cancer
• Real-world data of palbociclib in combination with endocrine therapy for the treatment of metastatic breast cancer in men

  Clinical Pharmacology & Therapeutics

  • Publications
  • Label expansion
  • Metastatic breast cancer
• Postmarket Real World Data Perspectives: IBRANCE (palbociclib) Males Case
  • Real-world evidence
  • Video
  • Case study
  • Label expansion
  • Webinar
• Kadcyla (T-DM1) in HER2+ mBC: Label Update on LVEF following a post approval commitment – based on RWD
  • Real-world evidence
  • Video
  • Case study
  • Label expansion
  • Regulatory
  • Post marketing requirements
  • Webinar
• Characteristics and outcomes of real-world patients with microsatellite instability-high solid tumors treated with pembrolizumab monotherapy after FDA approval

  ASCO Annual Meeting

  • Real-world evidence
  • Publication summary
  • Publications
  • Treatment patterns
  • Label expansion
  • Tumor agnostic
• Challenges and opportunities to updating prescribing information for longstanding oncology drugs

  The Oncologist

  • Publications
  • Label expansion